Literature DB >> 30534249

Prolonged hyponatremia due to hypopituitarism in a patient with non-ST-elevation myocardial infarction.

Kyohei Marume1,2, Yuichiro Arima1,2, Motoyuki Igata3,2, Takeshi Nishikawa3,2, Eiichiro Yamamoto1,2, Megumi Yamamuro1,2, Kenichi Tsujita1,2, Tomoko Tanaka1,2, Koichi Kaikita1,2, Seiji Hokimoto1,2, Hisao Ogawa1,2.   

Abstract

A 58-year-old man was admitted for non-ST-elevation myocardial infarction. A medicated stent was used for severe coronary artery stenosis. However, consciousness level progressively deteriorated after angioplasty. Computed tomography showed no brain lesion but laboratory tests showed hyponatremia (serum sodium: 113 meq./l) and urine analysis showed syndrome of inappropriate antidiuretic hormone secretion (SIADH). SIADH was first suspected to be drug-induced by enalapril. However, hyponatremia persisted even after withdrawal of enalapril and required oral sodium intake. Hormone assays indicated secondary adrenal insufficiency, which was caused by adrenocorticotropic hormone (ACTH) deficiency. Furthermore, in addition to ACTH deficiency, adult growth hormone deficiency was diagnosed following tests. Treatment with hydrocortisone relieved hyponatremia and re-institution of enalapril did not reduce serum sodium concentration. The final diagnosis was hyponatremia caused by hypopituitarism. <Learning objective: Secondary adrenal insufficiency with subsequent hypopituitarism should be suspected in cases with sudden-onset and prolonged hyponatremia in acute illness. Furthermore, the management of hypopituitarism should include assessment of growth hormone release to exclude growth hormone deficiency.>.

Entities:  

Keywords:  Acute coronary syndrome; Growth hormone deficiency; Hyponatremia; Hypopituitarism

Year:  2014        PMID: 30534249      PMCID: PMC6279656          DOI: 10.1016/j.jccase.2014.08.002

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  11 in total

1.  Hyponatremia is an independent predictor of adverse clinical outcomes in hospitalized patients due to worsening heart failure.

Authors:  Sanae Hamaguchi; Shintaro Kinugawa; Miyuki Tsuchihashi-Makaya; Shouji Matsushima; Mamoru Sakakibara; Naoki Ishimori; Daisuke Goto; Hiroyuki Tsutsui
Journal:  J Cardiol       Date:  2013-09-08       Impact factor: 3.159

Review 2.  The hyponatremic patient: a systematic approach to laboratory diagnosis.

Authors:  Haralampos J Milionis; George L Liamis; Moses S Elisaf
Journal:  CMAJ       Date:  2002-04-16       Impact factor: 8.262

3.  Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline.

Authors:  Mark E Molitch; David R Clemmons; Saul Malozowski; George R Merriam; Mary Lee Vance
Journal:  J Clin Endocrinol Metab       Date:  2011-06       Impact factor: 5.958

4.  Increased cerebrovascular mortality in patients with hypopituitarism.

Authors:  B Bülow; L Hagmar; Z Mikoczy; C H Nordström; E M Erfurth
Journal:  Clin Endocrinol (Oxf)       Date:  1997-01       Impact factor: 3.478

5.  Hyponatremia and long-term mortality in survivors of acute ST-elevation myocardial infarction.

Authors:  Alexander Goldberg; Haim Hammerman; Sirouch Petcherski; Mithal Nassar; Alexander Zdorovyak; Sergey Yalonetsky; Michael Kapeliovich; Yoram Agmon; Rafael Beyar; Walter Markiewicz; Doron Aronson
Journal:  Arch Intern Med       Date:  2006-04-10

6.  Hyponatraemia and severity and outcome of myocardial infarction.

Authors:  C T Flear; P Hilton
Journal:  Br Med J       Date:  1979-05-12

7.  Recombinant human GH replacement increases CD34+ cells and improves endothelial function in adults with GH deficiency.

Authors:  Agatha A van der Klaauw; Alberto M Pereira; Ton J Rabelink; Eleonora P M Corssmit; Anton-Jan Zonneveld; Hanno Pijl; Hetty C de Boer; Johannes W A Smit; Johannes A Romijn; Eelco J P de Koning
Journal:  Eur J Endocrinol       Date:  2008-05-21       Impact factor: 6.664

Review 8.  Cardiovascular risk factors in hypopituitary GH-deficient adults.

Authors:  Johan Verhelst; Roger Abs
Journal:  Eur J Endocrinol       Date:  2009-08-14       Impact factor: 6.664

9.  Premature mortality due to cardiovascular disease in hypopituitarism.

Authors:  T Rosén; B A Bengtsson
Journal:  Lancet       Date:  1990-08-04       Impact factor: 79.321

10.  Hypothalamo-pituitary-adrenal axis in acute myocardial infarction treated by percutaneous transluminal coronary angioplasty: effect of time of presentation.

Authors:  F Paganelli; C Frachebois; J G Velut; S Boullu; N Sauze; J P Rosso; P Barnay; P Sbragia; R Gelisse; M Grino; S Levy; C Oliver
Journal:  J Endocrinol Invest       Date:  2003-05       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.